This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 May 2024 and includes updates on cholera and western equine encephalitis.
This report contains genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 August 2023 until 31 January 2024.
ECDC cooperates with international partners, such as the World Health Organization and the centres for disease control and prevention (CDCs) across the globe.
ECDC also cooperates with EU candidate countries, potential candidate countries, and European Neighbourhood Policy (ENP) countries.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
In the context of the antimicrobial resistance (AMR) conference of the Belgian EU presidency, with ECDC as one of the organisers, the Director participated in the high-level meeting ‘An EU Health Emergency’ in Brussels.
Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.